new rapid-acting insulin analog called NovoRapid (insulin aspart)
October 2001
You'll hear about a new rapid-acting insulin analog called NovoRapid (insulin aspart).
Novo Nordisk is now marketing it in the U.S. under the name Novolog. NovoRapid will be available in Canada early next year.
Think of it as similar to Humalog (insulin lispro).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive